Helen Chen is a Greater China Managing Partner of L.E.K. based in Shanghai. She was a member of L.E.K.’s Global Leadership Team from 2012 to 2016. Helen is also head of L.E.K.’s China and Asia Biopharmaceuticals & Life Sciences practice and has extensive case work and industry experience covering the full biopharmaceutical and medical devices value chain.

Helen has 30 years of consulting and industry experience in the U.S. and Asia markets and has resided in China since 2000. She helps companies expand their presence in China and leverages China’s resources to improve their global businesses. She is a frequent speaker and author on the opportunities and issues in China’s Healthcare and Life Sciences sectors.

Prior to joining L.E.K., Helen held senior management roles at a number of technology companies in the U.S. and China. She was an associate director of finance at Genentech and a sales planner at Abbott Laboratories. Helen has an honors degree in Applied Mathematics from Harvard University.

Education

Undergraduate: Bachelor of Arts, Harvard University

Helen's Expertise

Read More

Related Insights

Lung Cancer Drug Launch in the China Market - Case Study

In China, over one million people get lung cancer each year, and for six hundred thousand the disease is terminal. In one of the largest worldwide markets…
 

Lung Cancer Drug Launch in the China Market - Case Study

In China, over one million people get lung cancer each year, and for six hundred thousand the disease is terminal. In one of the largest worldwide markets…
 

The Impact of Government Policies and the Trade War on China's Healthcare Industry

Helen Chen, Greater China Managing Partner at L.E.K., discusses government initiatives in China’s fast-growing healthcare industry and the impact of the U…

The Impact of Government Policies and the Trade War on China's Healthcare Industry

Helen Chen, Greater China Managing Partner at L.E.K., discusses government initiatives in China’s fast-growing healthcare industry and the impact of the U…
Lung Cancer Drug Launch
Life Sciences & Pharma

Lung Cancer Drug Launch in the China Market - Case Study

Lung Cancer Drug Launch
Life Sciences & Pharma

Lung Cancer Drug Launch in the China Market - Case Study

Helen-Chen-Interview-Video
Life Sciences & Pharma

The Impact of Government Policies and the Trade War on China's Healthcare Industry

Helen-Chen-Interview-Video
Life Sciences & Pharma

The Impact of Government Policies and the Trade War on China's Healthcare Industry